According to G1 Therapeutics 's latest financial reports the company's current EPS (TTM) is -โน121.38. In 2022 the company made an earnings per share (EPS) of -โน288.07 an increase over its 2021 EPS that were of -โน301.75.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน117.43 | -59.24% |
2022 | -โน288.07 | -4.53% |
2021 | -โน301.75 | 34.22% |
2020 | -โน224.82 | -19.33% |
2019 | -โน278.67 | 26.36% |
2018 | -โน220.54 | -10.06% |
2017 | -โน245.21 | 68.91% |
2016 | -โน145.18 |